Literature DB >> 25742193

Silylated precision particles for controlled release of proteins.

Khosrow Khodabandehlou1, Amar S Kumbhar, Sohrab Habibi, Ashish A Pandya, J Christopher Luft, Saad A Khan1, Joseph M DeSimone1,2.   

Abstract

With the recent advances in the development of novel protein based therapeutics, controlled delivery of these biologics is an important area of research. Herein, we report the synthepan class="Chemical">sis of microparticles from bovine serum albumin (BSA) as a model protein using Particle Replication in Non-wetting Templates (PRINT) with specific size and shape. These particles were functionalized at room temperature using multifunctional chlorosilane that cross-link the particles to render them to slowly-dissolving in aqueous media. Mass spectrometric study of the reaction products of diisopropyldichlorosilane with individual components of the particles revealed that they are capable of reacting and forming cross-links. Energy dispersive spectroscopy (EDS) and X-ray photoelectron spectroscopy (XPS) were also used to confirm the functionalization of the particles. Cross sectional analysis using focused ion beam (FIB) and EDS proved that the functionalization occurs throughout the bulk of the particles and is not just limited to the surface. Circular dichroism data confirmed that the fraction of BSA molecules released from the particles retains its secondary structure thereby indicating that the system can be used for delivering protein based formulations while controlling the dissolution kinetics.

Entities:  

Keywords:  bovine serum albumin; controlled release; diisopropyldichlorosilane; functionalization; protein delivery; silylation

Mesh:

Substances:

Year:  2015        PMID: 25742193      PMCID: PMC4545247          DOI: 10.1021/am508520z

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  44 in total

1.  Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying.

Authors:  Henry Nettey; Dinesh Haswani; Carl W Oettinger; Martin J D'Souza
Journal:  J Microencapsul       Date:  2006-09       Impact factor: 3.142

Review 2.  Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems.

Authors:  Davis Yohanes Arifin; Lai Yeng Lee; Chi-Hwa Wang
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

Review 3.  Solid lipid nanoparticles as a drug delivery system for peptides and proteins.

Authors:  António J Almeida; Eliana Souto
Journal:  Adv Drug Deliv Rev       Date:  2007-05-01       Impact factor: 15.470

4.  Shape-specific, monodisperse nano-molding of protein particles.

Authors:  Jennifer Y Kelly; Joseph M DeSimone
Journal:  J Am Chem Soc       Date:  2008-04-01       Impact factor: 15.419

Review 5.  Therapeutic application of peptides and proteins: parenteral forever?

Authors:  Zuzana Antosova; Martina Mackova; Vladimir Kral; Tomas Macek
Journal:  Trends Biotechnol       Date:  2009-09-18       Impact factor: 19.536

Review 6.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 7.  Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.

Authors:  Felix Kratz
Journal:  J Control Release       Date:  2008-05-17       Impact factor: 9.776

8.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.

Authors:  John F Carpenter; Theodore W Randolph; Wim Jiskoot; Daan J A Crommelin; C Russell Middaugh; Gerhard Winter; Ying-Xin Fan; Susan Kirshner; Daniela Verthelyi; Steven Kozlowski; Kathleen A Clouse; Patrick G Swann; Amy Rosenberg; Barry Cherney
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

9.  Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration.

Authors:  Majid Abrishami; Siamak Zarei-Ghanavati; Dina Soroush; Majid Rouhbakhsh; Mahmoud R Jaafari; Bizhan Malaekeh-Nikouei
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

10.  Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles.

Authors:  Maria A Miller; Joshua D Engstrom; Baltej S Ludher; Keith P Johnston
Journal:  Langmuir       Date:  2010-01-19       Impact factor: 3.882

View more
  2 in total

1.  Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.

Authors:  Erin M Wilson; J Christopher Luft; Joseph M DeSimone
Journal:  Pharm Res       Date:  2018-08-23       Impact factor: 4.200

2.  Particles for Local Delivery of Proteins Using Intra-Articular Route.

Authors:  Khosrow Khodabandehlou; Shaomin Tian; James C Luft; Saad A Khan; Joseph M DeSimone
Journal:  Adv Healthc Mater       Date:  2016-02-02       Impact factor: 9.933

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.